Circulation favors placenta over brain in fetuses of diabetic mothers

December 10, 2016

Leipzig, Germany - 10 December 2016: Blood flows preferentially to the placenta instead of the brain in foetuses of mothers with diabetes, reveals research presented today at EuroEcho-Imaging 2016.1

The annual meeting of the European Association of Cardiovascular Imaging (EACVI), a registered branch of the European Society of Cardiology (ESC), is held 7 to 10 December 2016 in Leipzig, Germany.

"We know that maternal diabetes mellitus affects the foetal organs," said lead author Dr Aparna Kulkarni, a paediatric cardiologist from the Bronx-Lebanon Hospital Centre, New York, USA. "Babies born to mothers with diabetes are sometimes bigger, especially if the diabetes is uncontrolled, and the placenta is larger. There is data to suggest that some other organs such as the pancreas and the kidneys in the foetus might be affected."

Dr Kulkarni's previous research identified subclinical changes in the heart muscle of foetuses of mothers with diabetes. In the current study she investigated whether these foetuses had changes in blood circulation.

This study included 14 foetuses of mothers with type 1 or 2 diabetes and 16 foetuses of mothers without diabetes (control group). Nine of the diabetic mothers used insulin, three took oral medications, and two used diet alone to control their glucose levels.

The researchers used foetal Doppler echocardiography to measure blood flow to the brain, the left and right outflow tracts of the heart, the aorta, and the placenta. The data was plugged into a computerised model that mimics the foetal circulation. This model was developed by Dr Patricia Garcia-Canadilla in the Physense research laboratory of Dr Bart Bijnens at the University of Pompeu Fabra, Barcelona, Spain.

This research found that, compared to foetuses in the control group, in foetuses of diabetic mothers more blood flowed to the placenta and was diverted away from the brain. Specifically, foetuses of diabetic mothers had lower placental resistance and compliance, lower blood flow to the arteries in the brain (measured from the cerebral artery radius), a reduced proportion of blood flow to the brain than the placenta and a lower cardiac output.

Dr Kulkarni said: "The computational model equivalent of the foetal circulation is an electrical circuit where there are resistances and compliances. It is easier for blood to flow to the placenta, and harder for blood to flow to the brain."

Dr Kulkarni said the placenta in foetuses of diabetic mothers have changes in their blood vessels and are known to be large; therefore likely receive more blood supply. But she added that the lower proportion of blood supplying the brain is an interesting finding and could have bigger implications.

"The placenta gets taken away after a baby is born so it's no longer a part of the circulation," she said. "But it's possible that the reduced circulation to the brain in utero could affect the baby through life. We don't know enough about why this redistribution of blood flow occurs or the implications it might have. More research is needed to find out if this has any long-term impact on the health of the baby and whether anything can be done to prevent it."

She concluded: "At the present time, I don't think any changes should be made in management of pregnant women with diabetes mellitus based on these findings. Standard obstetric recommendations for strict glucose control and healthy lifestyle should be continued."
-end-
Authors: ESC Press Office
Tel: +33 (0)4 89 87 24 83
Email: press@escardio.org

European Society of Cardiology

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.